Document is current
Any future updates will be listed below
-
Authors
Zhou, Cilla
Lavender, Isobel
Gordon, Rebecca
McCartney, Danielle
Kevin, Richard C.
Bedoya-Pérez, Miguel A.
McGregor, Iain S.
-
Funding
Funding for this research was provided by:
The Lambert Initiative for Cannabinoid Therapeutics (N/A, N/A, N/A, N/A, N/A, N/A, N/A)
- License Information
-
More Information
Article History
Received: 24 May 2024
Accepted: 30 December 2024
First Online: 4 February 2025
Declarations
:
: IM has acted as a consultant to Kinoxis Therapeutics and has received honoraria from Althea and Janssen. He is an inventor on several patents relating to novel cannabinoid and non-cannabinoid therapeutics. His research is funded by the Lambert Initiative and the Australian National Health and Medical Research Council (NHMRC). IM and DM have received consultancy income from the Medicinal Cannabis Industry Association (MCIA) of Australia and provided expert testimony in medicolegal cases related to cannabis. Other authors report no competing interests.
